Oral Administration of Bacterial β Cell Expansion Factor A (BefA) Alleviates Diabetes in Mice with Type 1 and Type 2 Diabetes

Diabetes mellitus (DM) is a group of metabolic diseases, and there is an urgent need to develop new therapeutic DM oral drugs with fewer side effects and sound therapeutic efficacy. In this study, a β cell expansion factor A (BefA) production strain of Escherichia coli (BL21-pet 28C-BefA) was constr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huan, Wei, Jing, Hu, Hong, Le, Fuyin, Wu, Heng, Wei, Hong, Luo, Jie, Chen, Tingtao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853770/
https://www.ncbi.nlm.nih.gov/pubmed/35186190
http://dx.doi.org/10.1155/2022/9206039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853770/
https://www.ncbi.nlm.nih.gov/pubmed/35186190
http://dx.doi.org/10.1155/2022/9206039

Ejemplares similares